More freedom for licensees after Supreme Court decision
With their recent MedImmune v Genentechjudgment, the nine Supreme Court justices have changed the licensing landscape in the US
Want to read more?
Register to access two of our subscriber-only articles per month
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts
Already registered? Log in
What our customers are saying
IAM magazine is, in my opinion, the premier magazine in the space of managing intellectual assets for value creation. It brings a fresh, business-driven perspective, rather than a purely legal perspective, on this issue. I would highly recommend it to anyone dealing with how to manage and drive value from intellectual assets.
David A VandenEinde
Assistant vice president and intellectual asset management leader
Cargill Inc
Benefits
Subscribe to receive access to the full range of premium business intelligence, insights and analysis, as well as our IP directories, guides and daily news.
